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Thymus-derived(T)  lymphocytes have  been  shown  to display  antigen  specificity. 
The antigen-recognition  units on T  lymphocytes, in contrast  to those on B  lympho- 
cytes,  do  not  appear  to  be  of the  conventional  immunoglobulin  (Ig)  type.  Recent 
studies from various laboratories  (1-5) have demonstrated that the antigen-specific T 
cell  factors  derived  from  helper  or  suppressor  T  cells  possess  the  antigen-binding 
moiety and the products of genes in the I  region of the H-2 complex, whereas no Ig 
constant determinant  has been defined. Antibodies against the variable (V) region of 
the Ig heavy chain  (Igh) a or against  idiotypes on the antibodies,  however, have been 
shown  to react  with  isolated  T  cell  receptors  for antigens  as  well  as  with  antigen- 
specific helper and suppressor T  cell factors (6-12). It is therefore suggested that the 
antigen-binding  structure  on  T  cell  antigen-recognition  units  shares  the  V  region 
markers  with  the  conventional  Ig on  B  cells.  In  this  sense,  the  antigen-recognition 
units on T  cells appear to possess a constant portion, as do Ig. However, the constant 
region determinants  on T  cell receptors or on antigen-specific T  cell  factors have so 
far not been defined. 
If T  cells utilize gene pools similar or identical to those coding for the V  region of 
Igh  (Igh-V),  it  is  possible  that  the  constant  region  determinants  of the  antigen- 
recognition units on T  cells, distinct from those of B cell Igh (Igh-C), are also encoded 
by genes linked to the Igh locus. In this respect, the immunization of mice with T  cells 
from Igh allotype congenic mice would be able to provide antibodies specific for new 
allotypic determinants  on the  constant  region of the  antigen-recognition  units  of T 
cells. 
Based on these assumptions,  Owen et  al.  (13-15)  have,  in  fact, been successful  in 
obtaining  antisera  reactive  to  the  allotypic  determinants  on  suppressor  T  cells  of 
Igh-1 a  mice  (Tsu  a)  encoded  by  genes  adjacent  to  the  Igh  constant-region  genes, 
Igh-C, on the side toward the prealbumin gene, Pre-1.  The Tsu a has been found to be 
expressed on Lyt-2  + suppressor T  cells. Furthermore,  the anti-Tsu a antisera stimulate 
suppressor T  cells of mice that have an appropriate Igh allotype and block the binding 
1  Abbreviations used in  this paper:  ARS, azobenzen arsonate; BPV, Bordetella pertussis vaccine; C, 
complement; Con A, concanavalin A; DNP, 2,4-dintrophenyl; FACS, fluorescence-activated ceil sorter; 
FCS, fetal calf serum; Igh, immunoglobulin heavy chain; Igh-C, constant region of the Igh; Igh-V, variable 
region of the Igh; KLH, keyhole limpet hemocyanin; NMS, normal BALB/c serum; PFC, plaque-forming 
cells; TaF,  augmenting  T  cell factor; TsF, suppressor T  cell factor; Tsu  a,  allotypic determinant  on 
suppressor T cells of Igh-l  a mice; V, variable. 
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of  idiotype-specific  suppressor  T  cells  to  the  idiotype-bearing  immunoglobulins. 
Therefore, products recognized by the antisera seem to be the conserved determinants 
on, or adjacent to, the antigen-binding site oft  cell receptors. No direct evidence has, 
however, demonstrated  that  the conserved allotypic determinants  are in fact on the 
antigen-recognition units of T  ceils. 
In this communication, we report that the alloantiserum  produced by lgh  allotype 
congenic pairs defines the conserved allotypic determinants  on the small population 
of T  cells that belong to Thy-1 dull-stained Lyt-2- or Lyt-2  + T  cells of mice expressing 
lgh-lb  allotype. The allotypic determinants recognized by the antiserum are expressed 
on the antigen-binding moiety of the functionally different T  cell factors (i.e.,  antigen- 
specific helper and suppressor T  cell factors). Both of the determinants are considered 
to  be  encoded  by  genes  located  in  the  right  side  of the  lgh-V  locus  on  the  12th 
chromosome. Furthermore, the product on the antigen-specific suppressor T  cell factor 
defined  by the  antiserum  is  distinct  from that  on the  antigen-specific  helper  (aug- 
menting)  T  cell factor. 
Materials  and Methods 
Animals.  BALB/c CrSlc (H-2 a, Igh-la),  C57BL/6 CrSlc (H-2 b, lgh-lb),  and  C3H/HeSlc 
(H-2 k, lgh-1 j) mice were purchased from Shizuoka Experimental Animal Laboratory, Co. Ltd., 
Hamamatsu, Japan. bSJL/J (1-1-2  s, lgh-1 b)  and allotype congenic mice, CB-20 (H-2 a, lgh-1 b), 
b  j  BAB-14 ~H-2  , 1~h-1  ), SJA/Hz (H-2 , lgh-1  ), C3H.SW/Hz (CSW; H-2  , lgh-1 ), and CWB/ 
Hz (H-2  , lgh-I  )  were kindly provided by Dr.  K.  Okumura,  Department  of Immunology, 
Faculty of Medicine, University of Tokyo, Japan. 
Antigens.  Keyhole limpet  hemocyanin  (KLH)  was  purchased  from  Calbiochem-Behring 
Corp., American Hoechst Corp.,  San  Diego, Calif.  Dinitrophenylated  KLH  (DNP770-KLH) 
was prepared  by coupling with  2,4-dinitrobenzenesulfonic acid under an alkaline condition. 
BordeteUa pertussis vaccine (BPV) was purchased from the Chiba Serum Institute, Chiba, Japan. 
Antisera.  The BALB/c anti-CB-20 alloantiserum  was prepared  by hyperimmunization of 
BALB/c mouse intravenously with 1 ×  107 of CB-20 spleen cells precultivated with 5 #g/ml of 
concanavalin A  (Con A; Sigma Chemical Co., St.  Louis, Mo.) for 48 h at 37°C in a 5% CO2 
incubator. The Con A-stimulated CB-20 spleen cells were treated with 100 #g/ml of mitomycin 
C  (Kyowa Hakko Kogyo Co. Ltd., Tokyo, Japan)  for 45 min at  37°C before immunization. 
The animals were immunized weekly,  and beginning at the  1  lth wk, they were partially bled 
from a  tail vein immediately before each immunization. The serum bled from each animal 
every week was pooled to make one lot  and  stored at  -80°C before use.  Only lot  2 of the 
antiserum  was used in the studies.  Monoclonal mouse IgM anti-Thy-l.2  (F7D5)  was kindly 
provided by Dr.  P.  Lake, Georgetown University,  Wash.,  D.  C.  Monoclonal rat  antibodies 
against  Lyt-1  (53-7.3),  Lyt-2 (53-6.7),  Thy-l.2  (30-H-12),  and  affinity-purified mouse  (SJL) 
anti-rat  Ig were gifts from Dr. J. A. Ledbetter, Department of Genetics, Stanford University, 
Stanford, Calif. 
Cytotoxic Test.  The two-step cytotoxic assay was performed.  10 #1 of 1 ×  107/ml  lymphoid 
cells from different tissues  suspended in RPMI  1640 medium containing  1% fetal calf serum 
(FCS)  and t9.1% NaN3 was incubated with  10 #1 of diluted antiserum for 30 rain at 4°C. After 
one washing the cells were treated with 20 #1 of a  1:8 diluted rabbit complement (C) for 30 min 
at 37°C. Live and dead cells were counted under a  light  microscope by the trypan blue dye 
exclusion method. Percent cytotoxicity was calculated by the following formula: 
percent dead experimental -  percent dead C control 
percent cytotoxicity ffi  ×  i00. 
100% -  percent dead C control 
200 cells were counted per well in the dye exclusion cytotoxic assay. 
Quantitative  Absorption of BALB/c  Anti-CB-20  Antiserum  with  Cells.  Quantitative  absorption 
studies  were  carried  out  in  a  V-bottomed  microtiter  plate  (Dynatech  Laboratories,  Inc., 128  DETERMINANTS ON  T  CELL FACTORS CODED  BY  Igh-LINKED GENES 
Dynatech  Corp., Alexandria,  Va.).  30 #l of the  1:10 diluted  antiserum  that  showed  the end 
point  of maximum  cytotoxicity was  absorbed  with  graded  numbers  of lymphoid  cells from 
various strains of mice for  1 h  at 4°C. The supernatants  were collected by centrifugation and 
then tested for their eytotoxic activities on C57BL/6 thymocytes. 
Cytotoxic Treatment of Spleen Cells with  a Monoclonal Anti-Thy-l.2.  10  million/ml C57BL/6 
spleen cells were reacted with  10/zg of monoclonal mouse anti-Thy-l.2  (F7D5)  antibodies for 
30  rain  at  room  temperature.  The  cells were washed  once and  incubated  with  1:10  diluted 
guinea pig C  for 45 min at  37°C. The cells were again  treated  with anti-Thy-l.2  and C  and 
then fractionated by Ficoll-Conley (Pharmacia  Fine Chemicals, Uppsala,  Sweden)  to remove 
dead cells. 
Purification of T  Cells from Spleen Cells by a Nylon Wool Column.  Spleen cells from C57BL/6 
mice were fractionated with a  nylon wool column (LP-1  Leukopack Leukocyte Filters; Fenwal 
Inc., Walter Kidde & Co. Inc., Ashland, Mass.)  by the method of Julius et al.  (16).  A yield of 
lymphoid  cells from  the nylon  wool column  was  ~15%  unfractionated  spleen  cells.  Purified 
populations  contained  ~75%  Thy-l-positive cells and  <1%  of surface  Ig-positive cells by  a 
membrane fluorescence technique. 
Cell Surface Staining.  1 million lymphocytes in  100/.tl  RPMI  1640  medium  containing  1% 
FCS and 0.1% NaN3 were reacted with  1 btg of monoclonal rat antibody  (anti-Lyt-1, anti-Lyt- 
2, or anti-Thy- 1.2) for 30 min at 4°C. Cells were washed twice and then stained with fluorescein- 
conjugated  mouse anti-rat  Ig reagents  for 30  rain  at  4°C.  Stained  cells were analyzed  by a 
fluorescence-activated  cell sorter  (FACS-IV;  B-D  FACS  Systems,  Becton,  Dickinson  &  Co., 
Sunnyvale, Calif.). 
Preparation of the KLH-specific Suppressor T Cell Factor (TsF) and the KLH-specific Augmenting T 
Cell Factor (TaF).  The methods for obtaining KLH-specific TsF and TaF have been described 
in detail elsewhere (1, 2).  In brief, mice were immunized intraperitoneally twice with 200 #g of 
KLH  at  2-wk  intervals.  2  wk  after  the  last  immunization,  thymocytes  or  spleen  cells from 
C57BL/6 or BALB/c mice were obtained and subsequently disrupted by freezing and thawing. 
The  cell-free extracts  were obtained  by  uhracentrifugation  at  40,000  g  for  1 h.  Monoclonal 
KLH-TsF was extracted by the same method as above (17)  from suppressor T  cell hybridoma 
(34S-704)  made by a  fusion of AKR thymoma cells (BW5147)  and KLH-specific suppressor T 
cells from C57BL/6 mice. 
Absorption and Elution of KLH-TsF and KLH-TaF with Immunoadsorbent Columns.  10 mg KLH 
or 1 ml gamma globulin fraction of antisera was coupled with 1 ml of Sepharose 4B (Pharmacia 
Fine Chemicals)  by the method  of Ax~n et  al.  (18).  They  were packed  in a  1-ml disposable 
plastic syringe. The KLH-TsF or KLH-TaF was applied to the immunoadsorbent columns and 
incubated for 1 h at 4°C. Effluent was collected by passing through the columns. After extensive 
washing with RPMI  1640  medium, the active materials were eluted from the columns with 2 
ml  of 0.175  M  glycine  HC1  buffer,  pH  3.2,  at  4°C.  The  eluted  materials  were  instantly 
neutralized with  1 M  sodium bicarbonate and dialyzed with phosphate-buffered  saline. They 
were then concentrated by vacuum pressure.  Both effluent and eluate were tested  for activity 
in the in vitro secondary antibody response as described below. 
In some experiments, monoclonal KLH-TsF extracted  from  1 ×  109 hybridoma cells (34S- 
704) was absorbed with the BALB/c anti-CB-20 column to cover the reactive sites of antibodies 
specific for TsF. After washing the column with 20 ml chilled medium  (RPMI  1640),  it was 
incubated with medium for 1 h at 0°C. Effluent from the column was then added to the culture 
of DNP-KLH spleen cells on day 0 or day 2,  and  then tested  for activity to confirm whether 
monoclonal  KLH-TsF  was  discharged  from  the  column  during  the  incubation.  Spleen  cell 
extract from KLH-primed C57BL/6 mice equivalent to 1 ×  10  7 cells was subsequently absorbed 
with the monoclonal KLH-TsF preabsorbed  column of the anti-CB-20.  Activity of KLH-TsF 
or KLH-TaF in the effluent or the eluate from the column was tested in the in vitro antibody 
response by addition of the. materials to the culture on day 0 or day 2. 
In  Vitro Culture System.  4 million spleen cells from C57BL/6 or BALB/c mice primed 6 wk 
previously with 100 #g of DNP-KLH and  109 BPV were cultured in the Mishell-Dutton system 
in the presence of 0.1  #g/ml of DNP-KLH at 37°C in 5% CO2 in air for 5 d. For assaying the 
TsF or the TaF activity, the cell-free extract from 1 X  10  7 KLH-primed spleen or thymus cells, 
or 5 ×  105 hybridoma cells were added to the culture on day 0 or day 2, respectively. 5 d  later, TAKESHI  TOKUHISA  AND  MASARU  TANIGUCHI  129 
the numbers of anti-DNP IgG plaque-forming cells (PFC) were assayed by using DNP-coupled 
erythrocytes. 
Statistical Analysis.  For in vitro assays, results  were analyzed with a two-tailed Student's t 
test. Probability values of > 10% were considered  to be insignificant. 
Results 
T Cell Reactivity ofBALB/c Anti-CB-20 Antiserum.  The allotype congenic mice pairs, 
BALB/c (H-2 d, Igh-! a) and CB-20 (H-2 d, Igh-] b), were used to produce the antiserum 
used  in  this study.  It seemed possible that  the antiserum  would  contain  antibodies 
against the allotypic determinants on T  cell surfaces encoded by genes linked to the 
Igh genes, as previous studies have suggested that the antigen-recognition units on T 
cells carry the determinants shared with the Igh- V gene products.  To investigate the 
reactivity of the BALB/c anti-CB-20 antiserum to T  cells, the antiserum was absorbed 
with graded numbers of unfractionated thymus or spleen cells of C57BL/6 (Igh-1 b) or 
BALB/c  (Igh-I ~)  mice,  or  anti-Thy-l-treated  C57BL/6  spleen  cells.  The  residual 
cytotoxic  activity  of  the  antiserum  thus  absorbed  was  then  tested  on  C57BL/6 
thymocytes as a  target. Fig.  1 shows that spleen cells and thymocytes from C57BL/6 
but not from BALB/c mice completely absorbed the cytotoxic activity of the antise- 
rum.  The  reactivity  of the  antiserum  to  the  C57BL/6  thymocytes was  preserved, 
however, even when the antiserum was absorbed with 5 ×  106 C57BL/6 spleen cells 
treated twice with anti-Thy-1  and C. The results clearly indicate  that  the BALB/c 
anti-CB-20 antiserum is specific for the products on T  cells but not on B cells. 
Genetic Specificity of BALB/c  Anti-CB-20  Antiserum.  To  demonstrate  the  genetic 
specificity of the BALB/c  anti-CB-20  antiserum,  the reactivity was investigated by 
the dye exclusion cytotoxic assay on thymocytes derived from various strains of mice 
including allotype congenic mice: C57BL/6  (H-2 b, Igh-lb),  BALB/c (H-2 d, Igh-l~), 
BAB-14 (H-2 a, Igh-lb),  SJL (H-2 ~, Igh-lb),  SJA (H-2 s, Igh-l~),  C3H (H-2 k, Igh-lJ), 
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FIG.  l.  Reactivity  of BALB/c  anti-CB-20  antiserum  against  T  cells.  Quantitative  absorption 
analyses of the antiserum with [ymphocytes were carried out.  30/~l of the  1:10  diluted antiserum 
was absorbed with graded numbers of unfractionated thymus or spleen cells from C57BL/6 (Igh-I b) 
or BALB/c (Igh-1 a)  mice or C57BL/6 spleen cells treated  with anti-Thy-I  and C.  The  residual 
cytotoxic activity of the antiserum thus absorbed was tested on C57BL/6 thymocytes (see Materials 
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Fro.  2.  Genetic  specificity  ofBALB/c anti-CB-20 antiserum. (a) Cytotoxic  activity of  the antiserum 
on thymocytes  from various strains of mice, i.e,, C57BL/6 (Igh-I b) (×), BALB/e (Igh-I '~) (B), BAB- 
14 (Igh-I  b) ([]), CWB (Igh-I b) (A), C3H (Igh-U) (+), CSW (Igh-U) (&), SJL (Igh-I n) (O), and SJA 
(Igh-1 ~') (O). (b) Quantitative absorption  of 1:10 diluted anti-CB-20  antiserum with graded numbers 
of thymocytes  from various strains of mice. The residual cytotoxic  activity of the absorbed  antiserum 
was tested on C57BL/6 thymocytes.  Symbols  are the same as those in a. Background was <5%. 
killed  15-20%  of the  thymocytes  from  C57BL/6,  BAB-14,  CWB,  and  SJL  mice, 
whereas no cytotoxic activity was observed on those from BALB/c, C3H, CSW, and 
SJA  mice.  All  mouse strains  sensitive  to  the  antiserum  carry Igh-1 b allotype with 
different  genetic background.  It is clear that  the antiserum  recognizes the products 
expressed on T  cells from Igh-1 b mice. 
The results shown in Fig.  2 a  were confirmed by quantitative absorption analysis. 
30 pl of the 1:10 diluted antiserum was absorbed with graded numbers of thymocytes 
from various strains of mice. The residual cytotoxic activity was tested on C57BL/6 
thymocytes. Fig.  2b  shows cytotoxic curves of the  antiserum  after absorption  with 
thymocytes from C57BL/6,  BAB-14, BALB/c, CWB, CSW,  SJL, or SJA mice. The 
cytotoxic activity of the antiserum was absorbed with thymocytes of C57BL/6, BAB- 
14, CWB, and SJL mice having lgh-lb allotype. No absorbing capacity was observed 
on  BALB/c,  CSW,  or  SJA  thymocytes. Therefore,  the  absorption  with lgh-1 b thy- 
mocytes always removed antibody reactivity. The data in Fig. 2 a and b suggest that 
the BALB/c anti-CB-20 antiserum contains antibodies directed against the allotypic 
determinants on T  cells that are coded for by genes linked to the Igh genes. Thus, the 
determinants detected by the antiserum were shown to be encoded by genes located 
in the right side of the Igh- V gene locus, because the recombinant inbred strain, BAB- 
14, carries the Igh-C linked genes on the inserted chromosomal segment from C57BL/ 
6 (Igh-I b) and the Igh-Vlinked  genes from BALB/c (Igh-1 a) mice (19). 
Tissue  Distribution  of Cells  Sensitive  to  BALB/c  Anti-CB-20.  To  study  the  tissue 
distribution of ceils sensitive to the antiserum, spleen, thymus, and lymph node cells 
from C57BL/6 mice were tested by a dye exclusion cytotoxic assay. The results shown 
in Fig. 3 demonstrate that the  1:10 diluted antiserum killed ~20% of the thymocytes 
(Thy-1 + >95%)  or the  lymph node cells  (Thy-1 + 40%),  and  5%  of the  spleen  cells 
(Thy-1 +  30%).  When  spleen  cells purified  with  the  nylon wool  column  (splenic T, 
Thy-1 + 75%, Ig  + <1%) were treated with the 1:I0 diluted antiserum and C, 25% were 
sensitive to the antiserum. These results indicate that some but not all peripheral T 
cells are also sensitive to the antiserum. 
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Fro.  3.  Tissue distribution of the cells sensitive to BALB/c anti-CB-20 antiserum. Cytotoxicity of 
the antiserum was tested on nylon wool column-purified splenic T  cells (O) and the unfractionated 
lymphoid cells from spleen (El), thymus (x), or lymph node (A) of C57BL/6 mice. The targets used 
contained >95% Thy-I +, <1% Ig  + cells in thymocytes, 30% Thy-1 +, 50%  Ig  + cells in spleen cells, 
40%  Thy-1 +, 40%  Ig  + cells in  lymph node cells, and  75%  Thy-I +, <1%  Ig  + cells in  nylon wool 
column-purified splenic T  cells. Background was <5%. 
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FIG. 4.  The cells sensitive to BALB/c anti-CB-20 in the subsets of splenic T  cells with Lyt-2- or 
Lyt-2  + phenotypes. C57BL/6 splenic T  cells purified with a  nylon wool column were treated with 
the anti-CB-20 and  C  (~)  or  with  NMS  and  C  (r-n). The cells thus  treated were reacted with 
monoclonal rat anti-Thy-l.2, anti-Lyt-1, or anti-Lyt-2 antibodies, followed by staining with fluo- 
rescein-conjugated mouse (SJL)  anti-rat Ig. They were subsequently analyzed by FACS-IV. The 
percentage of positively stained cells represents the analysis of 20,000  cells on FACS-IV. 
sensitive to the antiserum were investigated by membrane fluorescence technique and 
FACS analysis. C57BL/6 splenic T  cells were treated with the 1  : 10 diluted antiserum 
and C. The remaining cells were treated with monoclona! rat antibodies (anti-Lyt-1, 
anti-Lyt-2, or anti-Thy-1.2)  followed by staining with fluorescein-conjugated mouse 
anti-rat  Ig. Splenic T  cells treated with normal BALB/c serum  (NMS)  and C  were 
used as controls. The treated cells were analyzed by FACS IV. The results in Fig. 4 
demonstrate that  16-17% of Thy-1 + or Lyt-1 + population in the splenic T  cells were 
eliminated  by the  treatment  with  the  BALB/c  anti-CB-20  and  C.  Similarly,  ~5% 
Lyt-2  +  T  cells  were  shown  to  be sensitive  to  the  antiserum.  Thus,  the  antiserum 
contains antibodies reactive to some T  cells belonging to both Lyt-2- and Lyt-2  + T 
cells.  The results in Fig. 5 show the fluorescence profiles of the Thy-1 + splenic T  cells 
treated with BALB/c anti-CB-20 or NMS and C. The antiserum selectively eliminated 
the Thy-1 dull-stained population in the splenic T  cells. 
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Fie.  5.  Fluorescence profiles ofThy-1  + splenic T cells with or without treatment of BALB/c anti- 
CB-20. Splenic T cells (75% Thy-I + cells) purified with a nylon wool column were treated with the 
anti-CB-20  and  C  (m)  or  with  NMS  and  C  (--).  The  cells  were  subsequently reacted  with 
monoclonal  rat  anti-Thy-l.2 antibodies followed  by staining with fluorescein-conjugated  mouse 
(SJL) anti-rat Ig. Background  (cells stained with fluoreseein-conjugated  mouse anti-rat Ig) is shown 
as a dotted line.  Fluorescence  distributions were analyzed by FACS-IV fitted with a  logarithmic 
amplifier. 
TABLE  I 
Successful Absorption of the KLH- TsF  from C57BL/6 (Igh- 1 b) but Not from BALB/c (Igh- I a) Mice 
with the Column of BALB/c Anti-CB-20 
KLH-TsF absorbed 
with columns*  Materials added 
Anti-DNP IgG PFC/cuhure 
C57BL/6:~  P value  BALB/c§  P value 
--  --  4,020 +  18011  --  16,600 ±  1,700  -- 
--  Unabsorbed TsF  120 ±  50  <0.001  8,100 ±  900  <0.001 
BALB/c anti-CB-20  Effluent  3,180 +  360  NS¶  8,300 ±  200  <0.001 
BALB/c anti-CB-20  Eluate  550 -+ 390  <0.001  15,200  ±  1,600  NS 
KLH  Effluent  3,500 +  260  NS  15,800 ±  1,500  NS 
KLH  Eluate  950 ±  170  <0.001  6,800 ±  500  <0.001 
* The extract of spleen cells from KLH-primed mice equivalent to 1 ×  107 cells was absorbed to and eluted 
from immunoadsorbent columns.  The effluent  or the eluate of the C57BL/6 or BALB/c TsF from the 
columns was added to the culture of DNP-KLH-primed spleen ceils on day 0. 
DNP-KLH-primed spleen  cells from C57BL/6  mice were  cultured with the effluent or the eluate of 
C57BL/6 KLH-TsF from the columns. 
§ DNP-KLH-primed spleen  cells from  BALB/c mice were cultured with the effluent or the eluate of 
BALB/c KLH-TsF from the columns. 
]] Arithmetic means and standard deviations of four cultures. 
¶ Not significant. 
were designed to examine whether the determinants recognized by the BALB/c  anti- 
CB-20  were  related  to  the  antigen-recognition units  on  T  cells,  because the  factor 
derived  from suppressor T  cells was  found  to  bear  the antigen-binding  moiety  (1). 
The  KLH-TsF  obtained  from  C57BL/6  (Igh-1 b)  or  BALB/c  (Igh-1 ~)  mice  was 
absorbed with  the  immunoadsorbent  columns of KLH  or the BALB/c  anti-CB-20. 
The  absorbed materials were also eluted from the columns with glycine-HC1 buffer. 
Both effluent and eluate were added to the in vitro secondary response of DNP-KLH- 
primed  C57BL/6  or  BALB/c  spleen cells on  day  0  and  tested  for  their suppressor 
activities.  As  shown  in  Table  I,  the  suppressor  activity  of  the  KLH-TsF  from 
C57BL/6  mice  was  absorbed  to  and  eluted  from  the  column  of  the  anti-CB-20 
antiserum, whereas the BALB/c derived KLH-TsF  did not react to the same column. 
Furthermore,  the  factors  from  C57BL/6  and  BALB/c  mice  were  antigen  specific, 
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TAnLE  II 
Successful Absorption of the KLH- TaF  from C57BL/6 (Igh- 1 b) but Not from BALB/c (Igh- 1 a) Mice 
with the Column of BALB/c Anti-CB-20 
KLH-TaF absorbed 
with columns*  Materials added 
Anti-DNP IgG PFC/culture 
C57BL/6~:  P value  BALB/c§  P value 
--  --  5,280 ± 830[[  --  4,330 ±  1,130  -- 
--  Unabsorbed TaF  11,835  ±  835  <0.001  10,400  ±  500  <0.001 
BALB/c anti-CB-20  Effluent  5,680 ±  1,080  NS¶  11,550  ±  1,560  <0.01 
BALB/c anti-CB-20  Eluate  12,870 ±  795  <0.001  4,225 ±  835  NS 
KLH  Effluent  5,705 ±  600  NS  4,800 :t: 1,040  NS 
KLH  Eluate  11,385 ±  1,185  <0.001  10,100  ±  695  <0.01 
* The extract ofthymocytes from KLH-primed mice equivalent to 1 ×  107 cells was absorbed to and eluted 
from immunoadsorbent columns.  The effluent or the eluate of the C57BL/6 or BALB/c TaF from the 
columns was added to the culture of DNP-KLH-primed spleen cells on day 2. 
:~ DNP-KLH-primed spleen cells from C57BL/6  mice were cultured with the effluent or the eluate of 
C57BL/6 KLH-TaF from the columns. 
§ DNP-KLH-primed spleen  cells from  BALB/c mice were cultured with the effluent or the eluate of 
BALB/c KLH-TaF from the columns. 
[] Arithmetic means and standard deviations of four cultures. 
¶ Not significant. 
TAnLE  III 
Presence of Two Distinct Antibodies in BALB/c Anti-CB-20, Each of Which Defines the KLH-TsF or 
the KLH- TaF 
Anti-CB-20 column  Anti-DNP IgG PFC/culture 
Materials added 
Absorbed with  Subsequently  Monoclonal TsF  C57BL/6-extract added on 
absorbed with*  added on 
u~y0  ~ay0  ~t,,y 2 
--  --  --  2,050 3= 250:~  7,730 3=  195  5,090 ±  195 
--  --  Unabsorbed factor  500 ±  390  830 +  60  10,710 ±  685 
Monoclonal TsF§  --  Effluent  1,520 ±  190  NDII  ND 
Monoclonal TsF§  --  Eluate  170 ±  150  ND  ND 
Monoclonal Tsl~  Medium  Effluent  ND  7,210 3= 580  4,540 ±  670 
MonoclonaI TsF~  C57BL/6 factor  Effluent  ND  980 ±  670  5,380 3= 710 
Monoclonal TsF~  C57BL/6 factor  Eluate  ND  ND  10,430 +  720 
* The anti-CB-20 column, which  had  been absorbed  with a  large quantity of the monoclonal  KLH-TsF, was extensively washed and was 
further incubated with medium  (RPMI 1640) for  I h at 0°C. The effluent from  the column was then added to the culture on day 0 or day 
2, and was tested for the activity to confirm whether the active materials were discharged from  the column. Spleen cell extract from  KLH- 
primed 057BL/6 mice equivalent to 1 x  l0  T  cells was subsequently absorbed with the monoclonal TsF-preabsorbed  anti-CB-20 column. The 
effluent or the eluate from  the column was added to the culture of DNP-KLH-primed C57BL/6  spleen cells on day 0 or day 2 in order to test 
suppressor  or enhancing activity. 
:~ Arithmetic means and standard deviations of four  cultures. 
§ Monoclonal  KLH-TsF from  the T  cell  hybridoma  (34S-704)  equivalent  to 5  X  l0  b cells  was  absorbed  to  the anti-CB-20 column.  The 
absorbed  materials were eluted from  the column  with acid. The eluate or the effluent was tested for  its suppressor  activity in the in vitro 
secondary response  of DNP-KLH-primed C57BL/6 spleen cells. 
Jl Not done. 
¶ Monoclonal KLH-TsF in hybridoma extract equivalent to  1 x  109 cells  was applied to the anti-CB-20 column to cover the binding site of 
antibodies specific  for TsF. 
strongly suggest that the antiserum reacts to the allotypic determinants on the antigen- 
specific suppressor T  cell factor. 
Absorption  of KLH-TaF with the Column  of BALB/c Anti-CB-20.  It is known that the 
soluble  extract  obtained  from  KLH-primed  spleen  cells  or  thymocytes  augments 
antibody responses in an antigen-specific fashion when the factor was added to culture 
on day 2  (2).  Furthermore, antigen-specific TaF  was also found to bear the antigen- 134  DETERMINANTS  ON  T  CELL  FACTORS  CODED  BY  Igh-LINKED GENES 
binding moiety and the products encoded by genes in the I-A  subregion of the H-2 
complex (2). As a result, experiments were carried out to establish whether the KLH- 
TaF could have determinants detected by the BALB/c anti-CB-20. 
The KLH-TaF from primed spleen cells of C57BL/6 or BALB/c mice was absorbed 
with the immunoadsorbent columns of KLH or the antiserum. Augmenting activities 
in the effluent or the eluate from the columns were tested by addition of the materials 
to the in vitro secondary culture on day 2. Table II shows results demonstrating that 
KLH-TaF from both C57BL/6 and BALB/c mice were absorbed to and eluted from 
the  KLH  column.  The  column  composed  of the  anti-CB-20  antiserum,  however, 
absorbed KLH-TaF from C57BL/6 but not from BALB/c mice. These results indicate 
that  the  anti-CB-20  antiserum  also  detects  allotypic determinants  on  the  antigen- 
specific TaF. 
BALB/c Anti-CB-20 Defines  Two Distinct Allotypic Determinants  on the Antigen-recognition 
Units on  T  Cells,  Each of Which Is Expressed on the KLH-TaF or the KLH-TsF.  In our 
previous experiments,  monoclonal KLH-TsF derived  from T  cell  hybridoma  (34S- 
704)  made by the  fusion  of a  thymoma cell  line,  BW5147,  and  C57BL/6  (Igh-1 b) 
KLH-specific suppressor T  cells, was shown to have the same immunochemical and 
physicochemical properties as that  of conventional  KLH-TsF  (17,  20).  In fact, the 
results shown in the upper part of Table III demonstrate that the monoclonal KLH- 
TsF, like the C57BL/6-derived KLH-TsF, carried the determinants recognized by the 
anti-CB-20 antiserum, because activity of the monoclonal KLH-TsF was absorbed to 
and eluted from the anti-CB-20 column. 
Based  on  these  results,  experiments were  carried  out  to  investigate  whether  the 
determinants  on  the  KLH-TsF detected  by the  anti-CB-20  antiserum  are  distinct 
from those on the KLH-TaF. The anti-CB-20 column was incubated with monoclonal 
KLH-TsF in extracted materials equivalent to  1 ×  109 hybridoma cells at 0°C  for 1 
h,  and  then  extensively washed  with  the  medium.  500/11  RPMI  1640  was  further 
incubated with the column at 0°C for 1 h. The effluent from the column was added 
to the culture on day 0 or day 2 to test whether the active materials were discharged 
from the column during the  1-h incubation. As shown in Table III, the effluent from 
the anti-CB-20 column absorbed with a  large amount of the monoclonal KLH-TsF 
had no detectable suppressor and enhancing activities, indicating that active materials 
were not  discharged  from the column  during  incubation  with  medium.  Therefore, 
KLH-primed spleen  cell  extract  of C57BL/6  mice equivalent  to  1 ×  107  cells was 
subsequently absorbed with the anti-CB-20 column preabsorbed with a large amount 
of monoclonal  KLH-TsF.  Suppressor  or  enhancing  activity  in  the  effluent  or  the 
eluate from the column was tested in the in vitro secondary response by addition of 
materials  to  culture  on  day 0  or  day  2.  As  shown  in  the  lower  part  of Table III, 
enhancing activity was absorbed to and eluted from the column, whereas there was 
no longer any suppressor activity absorbed. These results indicate that the monoclonal 
KLH-TsF preabsorbed column  preserves the capacity to absorb KLH-TaF but  not 
KLH-TsF. 
Discussion 
It is known that  two distinct  types of T  cell factors, with different  functions,  are 
found  in  materials extracted  from spleen  or thymus cells of mice hyperimmunized 
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antihapten IgG PFC responses to DNP-KLH (1, 2, 21). Furthermore, we have clearly 
shown that both KLH-TsF and KLH-TaF bear the antigen-binding moiety and the 
products coded for by genes in the I  subregion of the H-2 complex (1, 2). Subregion 
specifieities of the I  region products on the KLH-specifie TsF and TaF were serolog- 
ically determined to be the I-J and I-A subregion of the H-2 complex, respectively (2, 
21). 
Immunochemical analyses of KLH-TsF derived from T  cell hybridomas have also 
shown that the suppressor factor is composed of two distinct polypeptide chains, i.e., 
the antigen-binding and the/-J-encoded chains in covalent or noncovalent association, 
whereas no Ig constant  region determinant  has been demonstrated  (1,  17,  20,  22). 
Recent  reports  from  various laboratories  (6-12)  have,  however, indicated  that  the 
antigen-specific helper and suppressor factors carry a structure analogous or identical 
to the V region of Igh. As a result, it is conceivable that at least two genes are involved 
in coding for the structural entity of antigen-specific T  cell factors: one located in the 
I subregion of the H-2 complex, and the other linked to the Igh genes. If the variable 
region of the antigen-binding moiety on the T  cell factors is encoded by genes in the 
Igh linkage group, the constant region determinants of the antigen-recognition units 
on T  cells or T  cell factors should be encoded by genes on the same chromosome as 
those  coding  for  the  antigen-binding  structure.  No  report,  however,  has  formally 
demonstrated  the  presence  of the  constant  region  determinants  on  the  antigen- 
recognition units on T  cells. 
In this respect, the combination of BALB/c and CB-20 mice is ideal for producing 
antibodies against the products encoded by genes in the Igh linkage group. The Igh 
allotype congenic mice, CB-20, are derived from a  cross between BALB/c (Igh-1 a) 
and C57BL/6 (Igh-ln),  and carry BALB/c background genes with the chromosomal 
segment of C57BL/6 origin that extends to somewhere around the Igh locus. Thus, 
the genetic difference between BALB/c and CB-20 mice is the Igh-linked genes on the 
12th chromosome. 
We have in  fact been successful in obtaining antibodies reactive to the allotypic 
determinants expressed on T cells ofIgh-1 b mice by repeated immunization of BALB/ 
c mice with Con A-stimulated CB-20 spleen cells. The BALB/c anti-CB-20 antiserum 
killed 5-20% Thy-1  + T  cells in the lymphoid organs including thymus, spleen, and 
lymph node (Figs.  3 and 4). The reactivity of the antiserum to the T  cell population 
was confirmed by the quantitative absorption analysis with lymphoid cells. As shown 
in  Fig.  1,  the  antibody activity was  completely absorbed  with  thymus  and  spleen 
cells,  whereas  spleen  cells  treated  twice  with  anti-Thy-1  and  C  (Thy-1  negative 
population)  did not absorb the reactivity to thymocytes at all. The results indicate 
that BALB/c anti-CB-20 antiserum definitely contains antibodies against the alloan- 
tigenic determinant on T cells but not on B cells. The products detected by antiserum 
were found to be expressed on splenic T  cells far more than on thymocytes, because 
2 ×  10  e spleen cells containing 30% T  cells (in which only 5% were sensitive to the 
antiserum)  (Fig. 3)  had the same capacity to absorb activity as 2 ×  106 thymocytes 
(Fig. 1). Moreover, the antiserum selectively killed the Thy-1 dull-stained population 
in splenic T  cells (Fig. 5). In general, T  cells lose Thy-1 antigens on their surface with 
the progression of maturation  (23). Thus,  mature T  cells are more sensitive to the 
antiserum than thymocytes. This is in agreement with the data reported by Owen et 
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The genetic specificity of the anti-CB-20 antiserum was determined  in  two ways. 
First,  the  antibody  activity  was  tested  by  the  dye  exclusion  cytotoxic  assay  on 
thymocytes from various strains of mice with different Igh allotypes. Second, quanti- 
tative absorption studies with thymocytes from various Igh allotype mice were carried 
out. The absorbed antiserum was then tested for cytotoxic activity on thymocytes of 
Igh-1 b mice.  From  these  experiments,  antibodies  were  shown  to  be  reactive  with 
thymocytes ofIgh-1 b mice but not ofIgh-1 '~ and Igh-1 j mice. It is clear then that the 
antiserum recognizes the allotypic determinants expressed only on T  cells of the Igh- 
I b mice, and that they are distinct  from B cell Igh allotype. 
The antiserum reacted more specifically to BAB-14 thymocytes. The recombinant 
inbred mice, BAB-14, are derived from a cross between BALB/c (Igh-1 a) and C57BL/ 
6  (Igh-1 b)  mice.  They  carry  the  Igh-V Dex,  the  anti-dextran  idiotype  locus,  from 
BALB/c,  and  the  Igh-C  genes  from  C57BL/6  mice  (19).  Therefore,  the  inserted 
chromosomal segment of C57BL/6 origin on the  12th chromosome of BAB-14 mice 
seems to be extended  from the cross-over point  between  the Igh-V and  the Igh-C to 
somewhere in the right side of the Igh-C. As shown in Fig.  2 b, antibody activity was 
completely absorbed with BAB-14 thymocytes. The results show conclusively that the 
antiserum has specificity to products of genes located in the right of the Igh- V genes. 
Similar observations have been  reported  by Owen  et  al.  (13-15),  demonstrating 
that the immunization of BALB/c mice with Con A-stimulated azobenzen arsonate 
(ARS)-primed CAL-20  splenic  T  cells  produced  antibodies  recognizing the surface 
products  (Tsu  a) of Lyt-2  ÷ suppressor T  cells. The Tsu a has been demonstrated to be 
controlled by a gene linked to the right side of the Igh gene cluster. Furthermore, the 
anti-Tsu  d antiserum can stimulate Lyt-2  + suppressor T cells that suppress the antibody 
responses to the unrelated antigens (sheep erythrocytes, DNP-KLH, and ARS-KLH) 
(14).  From these results, they have postulated that the Tsu  a antigen is associated with 
the T  cell receptor.  However, they have not  formally demonstrated  direct evidence 
that the anti-Ysu  a antiserum recognizes the determinants on the T  cell receptor. 
Our results, illustrated in Tables I and II, provided explicit evidence that the anti- 
CB-20  antiserum  recognized  the  determinants  on  the  antigen-binding  units  of the 
KLH-specific suppressor and enhancing T  cell factors, since the BALB/c anti-CB-20 
antiserum should not contain antibodies against the I  region gene products that are 
parts of the KLH-TsF and TaF.  Furthermore, we have recently confirmed that  the 
anti-CB-20 antiserum definitely reacts to the antigen-binding molecule on the KLH- 
TsF (T. Tokuhisa and M. Taniguchi, manuscript in preparation). 
As the anti-CB-20 antiserum was shown  to be reactive to the products controlled 
by  genes  in  the  right  side,  but  not  within  the  side  of Igh-V,  it  is  likely  that  the 
antiserum  reacts to  the allotypic determinants  of the  constant  region  of the  T  cell 
factors. However, we cannot exclude the possibility that the antiserum recognizes the 
allotypic  determinants  on  the  V  region  of the  antigen-binding  molecule  of T  cell 
factors if there are sets of T  cell  V gene clusters in the right side of the B cell Igh- V. 
A striking difference between Owen's (13-15) and our antisera is that our anti-CB- 
20 antiserum contains at least two distinct antibodies with different specificities:  the 
one  specific  for  antigen-specific  TsF,  and  the  other  for  the  antigen  specific  TaF. 
Owen's antiserum reacts only to the Lyt-2  + suppressor T  cells. As shown in Table III, 
the immunoadsorbent column of the anti-CB-20 preabsorbed with a large quantity of 
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1 b mice, while conventional KLH-TsF was no longer absorbed with the same column. 
These  results  were supported  by the  evidence  that  T  cells  sensitive  to  anti-CB-20 
belonged  to  both  Lyt-2- and  Lyt-2  ÷  populations  (Fig.  4),  each  of which  produces 
antigen-specific TaF and TsF. Consequently, it is apparent that antigen-specific TaF 
and TsF carry the  distinct  allotypic determinants on the antigen-recognition  units, 
both of which are encoded by genes located in the right side of Igh- V genes. 
The  allotypic  determinants  detected  by  the  anti-CB-20  antiserum  seem  to  be 
commonly shared within  each functional  activity of the respective T  cell factors, as 
preabsorption of the anti-CB-20 column with the monoclonal KLH-TsF completely 
eliminated antibody activity against the conventional  KLH-TsF (Table III). As the 
antiserum was produced by immunizations with unprimed Con A-stimulated CB-20 
spleen cells, it should not contain antibodies against idiotype-like determinants on the 
T  cell  antigen-receptors.  Thus,  it  is  conceivable that  allotypic  markers defined  by 
antiserum represent determinants on the antigen-binding molecules of antigen-specific 
T  cell factors outside of the antigen-binding site (i.e.,  constant region determinants). 
If so, every T  cell factor with a particular function may express a structurally related 
determinant like the Igh-C allotype. In this sense, it is reasonable to consider that the 
cluster  of genes  coding  for  different  allotypic  markers  on  the  constant  region  of 
functional T  cell factors or receptors is located somewhere around  the Igh-genes on 
the  12th chromosome. 
Summary 
The  alloantiserum  was  raised  in  BALB/c  (H-2 a, Igh-I a)  mice  hyperimmunized 
with spleen cells of Igh allotype congenic mice, CB-20 (Ho2 d, Igh-1 b). It was found to 
define  the  new  allotypic  determinants  (distinct  from  B  cell  Igh  constant  region 
determinants: Igh allotype) expressed only on a small population ofT cells belonging 
to the Thy-1  dull-stained  Lyt-2- or Lyt-2  + population of Igh-1 b mice. Genes coding 
for the determinants were shown to be accommodated somewhere in the right side of 
the Igh variable region gene (Igh-V) cluster, as the antibody activity was completely 
absorbed  with  BAB-14  thymocytes.  It  was  also  demonstrated  that  the  products 
detected  by the  antiserum  represent  the  allotypic determinants  (probably constant 
region determinants) on the antigen-binding moiety of the antigen-specific augment- 
ing (TaF) and suppressor (TsF) T  cell factors. Moreover, determinants on TsF were 
found to be distinct  from those on TaF. Therefore, it can be suggested that the two 
genes coding for the T  cell allodeterminants (distinct from those of the B cell Igh) are 
located in the right side of the B cell Igh-V on the  12th chromosome, and that both 
encode the antigen-recognition units of the functionally distinct T  cell factors. 
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